Discovery of flaw in system leads Rocky Mountain Health Plans to change policy regarding coverage of heavy babies.
Rocky Mountain Health Plans, Grand Junction, Colo., has made a companywide policy change and will now provide health plan coverage for healthy infants, regardless of their weight.
Alex Lange was denied coverage when he was two months old because his height and weight were in the 99th percentile according to Centers for Disease Control and Prevention guidelines. In light of the national healthcare reform debate, news outlets, bloggers and talk show hosts across the country covered the story, showing a healthy-looking Alex and interviewing his frustrated parents.
The situation brought attention to a “flaw in our underwriting program for approving infants,” says Steve ErkenBrack, president and CEO, Rocky Mountain Health Plans. “We have changed our policy, corrected our underwriting guidelines, and are working to notify the parents of the infant who we earlier denied.”
The flaw was attributed to a relatively new trend involving families seeking individual coverage for their children. Underwriting for this age group is a relatively new process, according to Rocky Mountain Health Plans.
“We are constantly working on new, innovative ways to deliver quality, affordable health plans that are designed for the people of Colorado,” says ErkenBrack.
Rocky Mountain Health Plans provides medical benefit plans and services to more than 170,000 enrollees in Colorado.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Positive Pipeline Updates for Friedreich’s Ataxia
October 24th 2024After experiencing setbacks, PTC reported positive results for vatiquinone, its selective inhibitor of 15-Lipoxygenase (15-LO) enzyme, regulator of the energetic and oxidative stress pathways that are disrupted in Friedreich ataxia
Read More